Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Knapp

Showing results (21-30 of 305) with videos related to

Pageof 31
Sort By:
International Anesthesiology Clinics|January 1, 1976
Management of "pelvic inflammatory disease"V C Donahue, R C Knapp
Important Advances in Oncology|January 1, 1987
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinomaR C Bast, R C Knapp
Current Oncology (Toronto, Ont.)|July 17, 2020
The challenge of creating evidence-based clinical practice guidelines for the use of hyperthermic intraperitoneal chemotherapy in the management of peritoneal malignanciesG C Knapp, L A Mack
Journal of Clinical Microbiology|January 1, 1992
Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamaseC C Knapp, J A Washington
Cleveland Clinic Journal of Medicine|March 1, 1989
Comparative activity of newer antibiotics against gram-negative bacilliC C Knapp, J A Washington
Obstetrics and Gynecology|January 1, 1977
Sexual rehabilitation of gynecologic cancer patientsV C Donahue, R C Knapp
IEEE Transactions on Bio-Medical Engineering|July 1, 1995
Spectral patterns and frequency response characteristics of arterial pressure in heart paced dogsM Wang, J Evans, C Knapp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Monoclonal antibodies and radioimmunoconjugates: keeping feasibility at center stageR C Knapp, C C Lau
Cleveland Clinic Journal of Medicine|September 1, 1988
In vitro comparison of activity of cefixime with activities of other orally administered antimicrobial agentsC C Knapp, J A Washington
American Journal of Obstetrics and Gynecology|August 1, 1977
Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer modelR C Knapp, R S Berkowitz
Pageof 31

Showing results (21-30 of 305) with videos related to

Sort By:
Pageof 31
International Anesthesiology Clinics|January 1, 1976
Management of "pelvic inflammatory disease"V C Donahue, R C Knapp
Important Advances in Oncology|January 1, 1987
The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinomaR C Bast, R C Knapp
Current Oncology (Toronto, Ont.)|July 17, 2020
The challenge of creating evidence-based clinical practice guidelines for the use of hyperthermic intraperitoneal chemotherapy in the management of peritoneal malignanciesG C Knapp, L A Mack
Journal of Clinical Microbiology|January 1, 1992
Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamaseC C Knapp, J A Washington
Cleveland Clinic Journal of Medicine|March 1, 1989
Comparative activity of newer antibiotics against gram-negative bacilliC C Knapp, J A Washington
Obstetrics and Gynecology|January 1, 1977
Sexual rehabilitation of gynecologic cancer patientsV C Donahue, R C Knapp
IEEE Transactions on Bio-Medical Engineering|July 1, 1995
Spectral patterns and frequency response characteristics of arterial pressure in heart paced dogsM Wang, J Evans, C Knapp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Monoclonal antibodies and radioimmunoconjugates: keeping feasibility at center stageR C Knapp, C C Lau
Cleveland Clinic Journal of Medicine|September 1, 1988
In vitro comparison of activity of cefixime with activities of other orally administered antimicrobial agentsC C Knapp, J A Washington
American Journal of Obstetrics and Gynecology|August 1, 1977
Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer modelR C Knapp, R S Berkowitz
Pageof 31